NCT05743257 How Urban Interventions in Lower Socioeconomic Areas Influence Health Behaviors (UrbASanté Study)
| NCT ID | NCT05743257 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Paris 12 Val de Marne University |
| Condition | Health-Related Behavior |
| Study Type | OBSERVATIONAL |
| Enrollment | 400 participants |
| Start Date | 2022-06-01 |
| Primary Completion | 2025-11-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 400 participants in total. It began in 2022-06-01 with a primary completion date of 2025-11-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The UrbASanté study is a quasi-experimental research that aimed at assessing the impact of urban transformations (a natural experiment) in the health related behaviors, environmental exposure and perceived- health.
Eligibility Criteria
Inclusion Criteria: * Living in areas with urban intervention in Porte de la Chapelle, Paris (for experimental group) * Living in areas without direct urban interventions close to Porte de la Chapelle, Paris (for control group) * Age above 18 years
Contact & Investigator
Helene Charreire
PRINCIPAL INVESTIGATOR
Paris 12 Val de Marne University
Frequently Asked Questions
Who can join the NCT05743257 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Health-Related Behavior. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05743257 currently recruiting?
Yes, NCT05743257 is actively recruiting participants. Contact the research team at helene.charreire@u-pec.fr for enrollment information.
Where is the NCT05743257 trial being conducted?
This trial is being conducted at Créteil, France.
Who is sponsoring the NCT05743257 clinical trial?
NCT05743257 is sponsored by Paris 12 Val de Marne University. The principal investigator is Helene Charreire at Paris 12 Val de Marne University. The trial plans to enroll 400 participants.